Related Experiment Video

Updated: Jun 12, 2026

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

Severe sirolimus-induced acute hepatitis in a renal transplant recipient

Jeremie Jacques1, Zara Dickson, Paul Carrier

  • 1Department of Hepatogastroenterology, CHU Dupuytren, Limoges, France.

Transplant International : Official Journal of the European Society for Organ Transplantation
|May 26, 2010
PubMed

Insights

Sirolimus, an immunosuppressant, can cause liver injury. This report details the first case of severe sirolimus-induced hepatitis in a kidney transplant patient, which resolved after drug withdrawal.

Area of Science:

  • Nephrology
  • Hepatology
  • Pharmacology

Background:

  • Sirolimus is a key immunosuppressant in kidney transplantation, valued for its antiproliferative effects and low nephrotoxicity.
  • Mammalian target of rapamycin (m-Tor) inhibitors, including sirolimus, are associated with various side effects, often reversible upon discontinuation.
  • Hepatotoxicity from m-Tor inhibitors is typically mild, presenting as transient elevations in transaminase levels.

Observation:

  • This case study presents a renal transplant recipient who developed severe acute hepatitis.
  • The condition was confirmed via liver biopsy and directly linked to sirolimus therapy.

Findings:

  • This represents the first documented instance of severe sirolimus-induced acute hepatitis in a kidney transplant recipient.
  • The patient's liver function normalized completely within weeks of discontinuing sirolimus treatment.

Implications:

  • Clinicians should be vigilant for potential severe hepatotoxicity, even if typically considered benign, when prescribing sirolimus.
  • This case highlights the importance of monitoring liver function in transplant patients on sirolimus and considering drug-induced liver injury.
  • Further research may be warranted to understand the mechanisms and risk factors for severe sirolimus-induced hepatotoxicity.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...